Abstract
Th17 and Th9 cells have been demonstrated to possess immune regulatory functions in malignant pleural effusion (MPE). However, whether IL-17 can affect differentiation and function of Th9 cells in MPE remains unknown. The objective of the present study was to explore the impact of IL-17 on the in vivo differentiation of Th9 cells in relation to Th2 cells in a murine model of MPE, and to explore whether IL-17 inhibits MPE formation via IL-9‒dependent mechanism. It was found that Th9 and Th2 cells were decreased in MPE from IL-17 –/– mice as compared with wild type mice. IL-17 deficiency inhibited Th9 and Th2 cell differentiation via suppressing transcription factors IRF4 and GATA-3, respectively. IL-17 deficiency enhanced MPE formation by promoting angiogenesis and proliferation of pleural tumors, and thus accelerated the death of mice bearing MPE. The in vivo administration of anti-IL-9 neutralizing mAb accelerated the death of WT mice; whereas administration of exogenous IL-9 improved the survival of IL-17 –/– mice. Our data provide the first definitive evidence that IL-17 promotes the differentiation of Th9 and Th2 cells in MPE. Our findings also demonstrate that IL-17 inhibits the formation of MPE and improves the survival of mice bearing MPE via an IL-9–dependent mechanism.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Adamson, A.S., Collins, K., Laurence, A., and O’Shea, J.J. (2009). The Current STATus of lymphocyte signaling: new roles for old players. Curr Opin Immunol 21, 161–166.
Beriou, G., Bradshaw, E.M., Lozano, E., Costantino, C.M., Hastings, W.D., Orban, T., Elyaman, W., Khoury, S.J., Kuchroo, V.K., Baecher-Allan, C., and Hafler, D.A. (2010). TGF-beta induces IL-9 production from human Th17 cells. J Immunol 185, 46–54.
Chen, Y.Q., Shi, H.Z., Qin, X.J., Mo, W.N., Liang, X.D., Huang, Z.X., Yang, H.B., and Wu, C. (2005). CD4+CD25+ regulatory T lymphocytes in malignant pleural effusion. Am J Respir Crit Care Med 172, 1434–1439.
Dardalhon, V., Awasthi, A., Kwon, H., Galileos, G., Gao, W., Sobel, R.A., Mitsdoerffer, M., Strom, T.B., Elyaman, W., Ho, I.C., Khoury, S., Oukka, M., and Kuchroo, V.K. (2008). IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3- effector T cells. Nat Immunol 9, 1347–135
De Monte, L., Reni, M., Tassi, E., Clavenna, D., Papa, I., Recalde, H., Braga, M., Di Carlo, V., Doglioni, C., and Protti, M.P. (2011). Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer. J Exp Med 208, 469–478.
Elyaman, W., Bradshaw, E.M., Uyttenhove, C., Dardalhon, V., Awasthi, A., Imitola, J., Bettelli, E., Oukka, M., van Snick, J., Renauld, J.C. (2009). IL-9 induces differentiation of TH17 cells and enhances function of Foxp3+ natural regulatory T cells. Proc Natl Acad Sci USA 106, 12885–12890.
Fischer, M., Bijman, M., Molin, D., Cormont, F., Uyttenhove, C., van Snick, J., Sundstrom, C., Enblad, G., and Nilsson, G. (2003). Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin’s lymphoma. Leukemia 17, 2513–2516.
Goswami, R., Jabeen, R., Yagi, R., Pham, D., Zhu, J., Goenka, S., and Kaplan, M.H. (2012). STAT6-dependent regulation of Th9 development. J Immunol 188, 968–975.
Kaplan, M.H., Schindler, U., Smiley, S.T., and Grusby, M.J. (1996). Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4, 313–319.
Kastelik, J.A. (2013). Management of malignant pleural effusion. Lung 191, 165–175.
Knoops, L., and Renauld, J.C. (2004). IL-9 and its receptor: from signal transduction to tumorigenesis. Growth Factors 22, 207–215.
Lin, H., Tong, Z.H., Xu, Q.Q., Wu, X.Z., Wang, X.J., Jin, X.G., Ma, W.L., Cheng, X., Zhou, Q., and Shi, H.Z. (2014). Interplay of Th1 and Th17 cells in murine models of malignant pleural effusion. Am J Respir Crit Care Med 189, 697–706.
Lu, Y., Hong, S., Li, H., Park, J., Hong, B., Wang, L., Zheng, Y., Liu, Z., Xu, J., He, J., Yang, J., Qian, J., Yi, Q. (2012). Th9 cells promote antitumor immune responses in vivo. J Clin Invest 122, 4160–4171.
Maier, E., Duschl, A., and Horejs-Hoeck, J. (2012). STAT6-dependent and-independent mechanisms in Th2 polarization. Eur J Immunol 42, 2827–2833.
Merz, H., Houssiau, F.A., Orscheschek, K., Renauld, J.C., Fliedner, A., Herin, M., Noel, H., Kadin, M., Mueller-Hermelink, H.K., and Van Snick, J. (1991). Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin’s disease and large cell anaplastic lymphoma. Blood 78, 1311–1317.
Nagato, T., Kobayashi, H., Kishibe, K., Takahara, M., Ogino, T., Ishii, H., Oikawa, K., Aoki, N., Sato, K., Kimura, S., Shimizu, N., Tateno, M., Harabuchi, Y. (2005). Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients. Clin Cancer Res 11, 8250–8257.
Nakae, S., Komiyama, Y., Nambu, A., Sudo, K., Iwase, M., Homma, I., Sekikawa, K., Asano, M., and Iwakura, Y. (2002). Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17, 375–387.
Nowak, E.C., Weaver, C.T., Turner, H., Begum-Haque, S., Becher, B., Schreiner, B., Coyle, A.J., Kasper, L.H., and Noelle, R.J. (2009). IL-9 as a mediator of Th17-driven inflammatory disease. J Exp Med 206, 1653–1660.
O'Shea, J.J., Lahesmaa, R., Vahedi, G., Laurence, A., and Kanno, Y. (2011). Genomic views of STAT function in CD4+ T helper cell differentiation. Nat Rev Immunol 11, 239–250.
Purwar, R., Schlapbach, C., Xiao, S., Kang, H.S., Elyaman, W., Jiang, X., Jetten, A.M., Khoury, S.J., Fuhlbrigge, R.C., Kuchroo, V.K., Clark, R.A., and Kupper, T.S. (2012). Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells. Nat Med 18, 1248–1253.
Roberts, M.E., Neville, E., Berrisford, R.G., Antunes, G., and Ali, N.J. (2010). Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax 65 Suppl 2, ii32–40.
Singh, T.P., Schon, M.P., Wallbrecht, K., Gruber-Wackernagel, A., Wang, X.J., and Wolf, P. (2013). Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis. PLoS One 8, e51752.
Staudt, V., Bothur, E., Klein, M., Lingnau, K., Reuter, S., Grebe, N., Gerlitzki, B., Hoffmann, M., Ulges, A., Taube, C., Dehzad, N., Becker, M., Stassen, M., Steinborn, A., Lohoff, M., Schild, H., Schmitt, E., and Bopp, T. (2010). Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33, 192–202.
Tamiya, T., Ichiyama, K., Kotani, H., Fukaya, T., Sekiya, T., Shichita, T., Honma, K., Yui, K., Matsuyama, T., Nakao, T., Fukuyama, S., Inoue, H., Nomura, M., and Yoshimura, A. (2013). Smad2/3 and IRF4 play a cooperative role in IL-9-producing T cell induction. J Immunol 191, 2360–2371.
Veldhoen, M., Uyttenhove, C., van Snick, J., Helmby, H., Westendorf, A., Buer, J., Martin, B., Wilhelm, C., and Stockinger, B. (2008). Transforming growth factor-beta “reprograms” the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 9, 1341–1346.
Ye, J., Livergood, R.S., and Peng, G. (2013). The role and regulation of human Th17 cells in tumor immunity. Am J Pathol 182, 10–20.
Ye, Z.J., Zhou, Q., Gu, Y.Y., Qin, S.M., Ma, W.L., Xin, J.B., Tao, X.N., and Shi, H.Z. (2010). Generation and differentiation of IL-17-producing CD4+ T cells in malignant pleural effusion. J Immunol 185, 6348–6354.
Ye, Z.J., Zhou, Q., Yin, W., Yuan, M.L., Yang, W.B., Xiang, F., Zhang, J.C., Xin, J.B., Xiong, X.Z., and Shi, H.Z. (2012a). Interleukin 22-producing CD4+ T cells in malignant pleural effusion. Cancer Lett 326, 23–32.
Ye, Z.J., Zhou, Q., Yin, W., Yuan, M.L., Yang, W.B., Xiong, X.Z., Zhang, J.C., and Shi, H.Z. (2012b). Differentiation and immune regulation of IL-9-producing CD4+ T cells in malignant pleural effusion. Am J Respir Crit Care Med 186, 1168–1179.
Ye, Z.J., Zhou, Q., Zhang, J.C., Li, X., Wu, C., Qin, S.M., Xin, J.B., and Shi, H.Z. (2011). CD39+ regulatory T cells suppress generation and differentiation of Th17 cells in human malignant pleural effusion via a LAP-dependent mechanism. Respir Res 12, 77.
Zheng, W., and Flavell, R.A. (1997). The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89, 587–596.
Zhou, M., and Ouyang, W. (2003). The function role of GATA-3 in Th1 and Th2 differentiation. Immunol Res 28, 25–37.
Zhou, Y., Sonobe, Y., Akahori, T., Jin, S., Kawanokuchi, J., Noda, M., Iwakura, Y., Mizuno, T., and Suzumura, A. (2011). IL-9 promotes Th17 cell migration into the central nervous system via CC chemokine ligand-20 produced by astrocytes. J Immunol 186, 4415–4421.
Zou, W., and Restifo, N.P. (2010). TH17 cells in tumour immunity and immunotherapy. Nat Rev Immunol 10, 248–256.
Acknowledgements
This work was supported by the National Natural Science Foundation of China (91442109, 31470883, 81270149, 81272591), and the National Basic Research Program of China (2012CB518706).
Author information
Authors and Affiliations
Corresponding authors
Additional information
This article is published with open access at link.springer.com
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Lu, Y., Lin, H., Zhai, K. et al. Interleukin-17 inhibits development of malignant pleural effusion via interleukin-9-dependent mechanism. Sci. China Life Sci. 59, 1297–1304 (2016). https://doi.org/10.1007/s11427-016-0097-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-016-0097-y